Senior insider sale
Chief Financial Officer at OPUS GENETICS, INC. — senior position signals high conviction
$64.4K
15.63K shares
What this filing means
GAGNON ROBERT E. plans to sell 15.63K shares of OPUS GENETICS, INC. valued at approximately $64.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/23/2026ACC: 0001974158-26-000091
Officer· Chief Financial Officer
Since Sep 2025
15.63K
Shares to sell
$64.4K
Approx. market value
7.78K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vested Restricted Stock Units
N/A
1/22/2026
7.78KTotal acquired7.78K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/22/2026 | Vested Restricted Stock Units N/A | 7.78K | — |
| Total | 7.78K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.84K
Market value
$40.7K
4/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.78K
Market value
$23.7K
7/23/2026
Total
Units
15.63K
Value
$64.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/23/2026 | 7.84K | $40.7K | — | Completed |
| Planned — Approximate Date | ||||
7/23/2026 | 7.78K | $23.7K | NASDAQ | Planned |
| Total | 15.63K | $64.4K | ||